Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Encompass Health Corp (NYSE: EHC) closed at $107.0 in the last session, up 0.14% from day before closing price of $106.85. In other words, the price has increased by $0.14 from its previous closing price. On the day, 1.15 million shares were traded. EHC stock price reached its highest trading level at $108.03 during the session, while it also had its lowest trading level at $106.45.
Ratios:
We take a closer look at EHC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 84.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.74. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In the most recent recommendation for this company, KeyBanc Capital Markets on October 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $115.
On July 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $100.
On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $95.Barclays initiated its Overweight rating on March 06, 2024, with a $95 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 27 ’25 when Tuer Patrick William sold 1,020 shares for $123.59 per share. The transaction valued at 126,062 led to the insider holds 18,846 shares of the business.
Patrick Tuer bought 1,020 shares of EHC for $126,062 on Aug 27 ’25. On May 20 ’25, another insider, Tarr Mark J, who serves as the President & CEO of the company, sold 118,384 shares for $121.53 each. As a result, the insider received 14,387,152 and left with 527,070 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EHC now has a Market Capitalization of 10777449472 and an Enterprise Value of 14191309824. As of this moment, Encompass’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.22, and their Forward P/E ratio for the next fiscal year is 18.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.86 while its Price-to-Book (P/B) ratio in mrq is 4.54. Its current Enterprise Value per Revenue stands at 2.449 whereas that against EBITDA is 10.739.
Stock Price History:
The Beta on a monthly basis for EHC is 0.75, which has changed by 0.09343016 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, EHC has reached a high of $127.99, while it has fallen to a 52-week low of $87.85. The 50-Day Moving Average of the stock is -9.03%, while the 200-Day Moving Average is calculated to be -6.96%.
Shares Statistics:
According to the various share statistics, EHC traded on average about 764.11K shares per day over the past 3-months and 913420 shares per day over the past 10 days. A total of 100.70M shares are outstanding, with a floating share count of 99.36M. Insiders hold about 1.25% of the company’s shares, while institutions hold 95.70% stake in the company. Shares short for EHC as of 1764288000 were 2552732 with a Short Ratio of 3.34, compared to 1761868800 on 1956680. Therefore, it implies a Short% of Shares Outstanding of 2552732 and a Short% of Float of 2.86.
Dividends & Splits
The forward annual dividend rate for EHC is 0.70, which was 0.7 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.00655124. The stock’s 5-year Average Dividend Yield is 1.15. The current Payout Ratio is 14.35% for EHC, which recently paid a dividend on 2025-10-01 with an ex-dividend date of 2026-01-02. Stock splits for the company last occurred on 2022-07-01 when the company split stock in a 1257:1000 ratio.
Earnings Estimates
. The current market rating for Encompass Health Corp (EHC) reflects the collective analysis of 12.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $1.5, with high estimates of $1.62 and low estimates of $1.4.
Analysts are recommending an EPS of between $5.46 and $5.27 for the fiscal current year, implying an average EPS of $5.32. EPS for the following year is $5.79, with 13.0 analysts recommending between $6.21 and $5.44.
Revenue Estimates
According to 11 analysts,. The current quarter’s revenue is expected to be $1.54B. It ranges from a high estimate of $1.55B to a low estimate of $1.53B. As of. The current estimate, Encompass Health Corp’s year-ago sales were $1.41BFor the next quarter, 11 analysts are estimating revenue of $1.58B. There is a high estimate of $1.59B for the next quarter, whereas the lowest estimate is $1.57B.
A total of 11 analysts have provided revenue estimates for EHC’s current fiscal year. The highest revenue estimate was $5.94B, while the lowest revenue estimate was $5.92B, resulting in an average revenue estimate of $5.93B. In the same quarter a year ago, actual revenue was $5.37BBased on 12 analysts’ estimates, the company’s revenue will be $6.44B in the next fiscal year. The high estimate is $6.5B and the low estimate is $6.39B.
